New Nordic Healthbrands Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van New Nordic Healthbrands is gedaald met een gemiddeld jaarlijks percentage van -62.2%, terwijl de winst van de Personal Products -industrie jaarlijks groeide met 3.8%. De inkomsten zijn groeide met een gemiddeld percentage van 3.9% per jaar.

Belangrijke informatie

-62.2%

Groei van de winst

-62.2%

Groei van de winst per aandeel

Personal Products Groei van de industrie	-19.2%
Inkomstengroei	3.9%
Rendement op eigen vermogen	-15.7%
Nettomarge	-2.8%
Volgende winstupdate	28 Feb 2025

Recente prestatie-updates uit het verleden

Recent updates

New Nordic Healthbrands (STO:NNH) Is Carrying A Fair Bit Of Debt

Nov 05

New Nordic Healthbrands AB (publ)'s (STO:NNH) Popularity With Investors Is Clear

Jul 03

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Oct 30

New Nordic Healthbrands (STO:NNH) Will Be Hoping To Turn Its Returns On Capital Around

Jul 31

Calculating The Intrinsic Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Jun 08

Estimating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Mar 08

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Feb 15

What Do The Returns On Capital At New Nordic Healthbrands (STO:NNH) Tell Us?

Jan 25

Should New Nordic Healthbrands AB (publ) (STO:NNH) Be Part Of Your Dividend Portfolio?

Dec 31

New Nordic Healthbrands AB (publ)'s (STO:NNH) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Dec 09

Opbrengsten en kosten

Hoe New Nordic Healthbrands geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

OM:NNH Opbrengsten, kosten en inkomsten (SEK Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
30 Sep 24	543	-15	362
30 Jun 24	549	-12	363
31 Mar 24	538	-10	358
31 Dec 23	534	-6	350
30 Sep 23	503	-4	328
30 Jun 23	490	1	315
31 Mar 23	490	-3	318
31 Dec 22	488	-3	322
30 Sep 22	497	-4	328
30 Jun 22	500	-4	334
31 Mar 22	510	12	329
31 Dec 21	515	21	321
30 Sep 21	512	28	312
30 Jun 21	502	28	302
31 Mar 21	466	23	283
31 Dec 20	450	18	284
30 Sep 20	447	20	280
30 Jun 20	449	25	279
31 Mar 20	461	27	288
31 Dec 19	453	28	279
30 Sep 19	436	31	268
30 Jun 19	430	30	264
31 Mar 19	409	28	253
31 Dec 18	394	27	243
30 Sep 18	383	26	232
30 Jun 18	358	22	217
31 Mar 18	352	23	207
31 Dec 17	345	20	204
30 Sep 17	329	14	199
30 Jun 17	325	12	197
31 Mar 17	312	10	191
31 Dec 16	306	10	185
30 Sep 16	310	12	186
30 Jun 16	300	10	180
31 Mar 16	300	11	179
31 Dec 15	298	11	178
30 Sep 15	294	12	173
30 Jun 15	285	13	166
31 Mar 15	284	13	163
31 Dec 14	272	12	155
30 Sep 14	261	10	151
30 Jun 14	254	7	148
31 Mar 14	238	7	142
31 Dec 13	228	6	137

Kwaliteitswinsten: NNH is momenteel verliesgevend.

Groeiende winstmarge: NNH is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: NNH is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 62.2% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van NNH over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: NNH is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Personal Products industrie ( 10.9% ).

Rendement op eigen vermogen

Hoge ROE: NNH heeft een negatief Return on Equity ( -15.72% ), omdat het momenteel verliesgevend is.

New Nordic Healthbrands Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Third quarter 2024 earnings released: kr0.28 loss per share (vs kr0.33 profit in 3Q 2023)

Second quarter 2024 earnings released: kr0.72 loss per share (vs kr0.50 loss in 2Q 2023)

First quarter 2024 earnings released: kr0.55 loss per share (vs kr0.094 profit in 1Q 2023)

New Nordic Healthbrands AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

Third quarter 2023 earnings released: EPS: kr0.33 (vs kr1.16 in 3Q 2022)

Second quarter 2023 earnings released: kr0.50 loss per share (vs kr1.21 loss in 2Q 2022)

Recent updates

New Nordic Healthbrands (STO:NNH) Is Carrying A Fair Bit Of Debt

Third quarter 2024 earnings released: kr0.28 loss per share (vs kr0.33 profit in 3Q 2023)

New major risk - Market cap size

Second quarter 2024 earnings released: kr0.72 loss per share (vs kr0.50 loss in 2Q 2023)

New Nordic Healthbrands AB (publ)'s (STO:NNH) Popularity With Investors Is Clear

First quarter 2024 earnings released: kr0.55 loss per share (vs kr0.094 profit in 1Q 2023)

New Nordic Healthbrands AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

New Nordic Healthbrands (STO:NNH) Is Making Moderate Use Of Debt

Third quarter 2023 earnings released: EPS: kr0.33 (vs kr1.16 in 3Q 2022)

New major risk - Market cap size

New Nordic Healthbrands AB (publ) Part Ways with Tage Juhl Finninge, Chief Commercial and Operating Officer

Does New Nordic Healthbrands (STO:NNH) Have A Healthy Balance Sheet?

Second quarter 2023 earnings released: kr0.50 loss per share (vs kr1.21 loss in 2Q 2022)

Is New Nordic Healthbrands (STO:NNH) A Risky Investment?

First quarter 2023 earnings released: EPS: kr0.094 (vs kr0.16 in 1Q 2022)

Chief Commercial Officer & COO recently bought kr140k worth of stock

Full year 2022 earnings released: kr0.46 loss per share (vs kr3.44 profit in FY 2021)

Chief Commercial Officer & COO recently bought kr202k worth of stock

Chief Commercial Officer & COO recently bought kr103k worth of stock

Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?

No independent directors

Third quarter 2022 earnings released: EPS: kr1.16 (vs kr1.08 in 3Q 2021)

Investor sentiment improved over the past week

New Nordic Healthbrands AB (publ) Appoints Tage Juhl Finninge as New Chief Commercial and Operating Officer

Now 24% undervalued after recent price drop

Calculating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Now 20% undervalued after recent price drop

Capital Allocation Trends At New Nordic Healthbrands (STO:NNH) Aren't Ideal

Investor sentiment deteriorated over the past week

New Nordic Healthbrands (STO:NNH) Has A Pretty Healthy Balance Sheet

Investor sentiment improved over the past week

Director recently bought kr102k worth of stock

Director recently bought kr91k worth of stock

Investor sentiment deteriorated over the past week

Capital Investment Trends At New Nordic Healthbrands (STO:NNH) Look Strong

No independent directors

Upcoming dividend of kr1.25 per share

Co-Founder recently sold kr316k worth of stock

Full year 2021 earnings released: EPS: kr3.44 (vs kr2.87 in FY 2020)

Director recently bought kr123k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?

Co-Founder recently sold kr386k worth of stock

Co-Founder recently sold kr378k worth of stock

Co-Founder recently sold kr196k worth of stock

Co-Founder recently sold kr155k worth of stock

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Co-Founder recently sold kr147k worth of stock

Second quarter 2021 earnings released: EPS kr1.41 (vs kr0.53 in 2Q 2020)

New Nordic Healthbrands (STO:NNH) Will Be Hoping To Turn Its Returns On Capital Around

Investor sentiment improved over the past week

Calculating The Intrinsic Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Investor sentiment improved over the past week

Upcoming dividend of kr1.50 per share

Full year 2020 earnings released: EPS kr2.87 (vs kr4.53 in FY 2019)

Estimating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Full year 2020 earnings released: EPS kr2.87 (vs kr4.53 in FY 2019)

New 90-day low: kr55.80

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

What Do The Returns On Capital At New Nordic Healthbrands (STO:NNH) Tell Us?

Should New Nordic Healthbrands AB (publ) (STO:NNH) Be Part Of Your Dividend Portfolio?

New Nordic Healthbrands AB (publ)'s (STO:NNH) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

New 90-day low: kr56.00

Third quarter 2020 earnings released: EPS kr1.04

New 90-day low: kr56.20

New 90-day low - kr56.80

New 90-day high - kr67.00